期刊文献+

变性高效液相色谱法检测结核分枝杆菌gyrA基因突变 被引量:1

Analysis of gyrA mutation in Mycobacteria tuberculosis by denaturing HPLC
原文传递
导出
摘要 目的 分析我国结核分枝杆菌氟喹诺酮类耐药基因gyrA突变的特点并探讨变性高效液相色谱法(DHPLC)的应用价值.方法 以结核分枝杆菌临床分离株109株(常规药敏试验显示87株氧氟沙星耐药,22株敏感)为对象,测定氧氟沙星最小抑菌浓度(MIC),同时进行gyrA基因氟喹诺酮类耐药决定区域(QRDR)DNA测序及DHPLC分析.结果 发现我国耐氧氟沙星结核分枝杆菌近来出现两个新的特点:一是gyrA QRDR双位点突变率高(87株耐药株中56.3%携有双位点突变);二是出现了以往认为的仅存在于其他细菌而在结核分枝杆菌中从未报道过的Ala74Ser突变(49株双位点突变耐药株中有20.4%携有该突变).gyrA基因突变类型与MIC之间并无密切关系.DHPLC测定中除常规的M.tb H37Rv以外还引入了M.tb Erdman做为参照菌株,成功地摆脱了95位AGC:ACC自然多态性的影响.与测序法相比较,DHPLC法的敏感度与特异度均达100%.结论 我国结核分枝杆菌氟喹诺酮类耐药已很严重,gyrA基因QRDR双位点突变率高为其特点.本研究建立的结核分枝杆菌gyrA基因突变的DHPLC分析法简便快速,稳定灵敏,在大面积大样本耐药监测以及临床快速药敏检测中有应用价值. Objective To analyze the characteristic of fluoroquinolone resistance gene gyrA mutation in Mycobacterium tuberculosis and to evaluate the value of denaturing HPLC(DHPLC) method.Methods One hundred and nine Mycobacterium tuberculosis clinical isolates among which 87 were found ofloxacin-resistant while 22 susceptible according to routine method,received minimal inhibitory concentration (MIC) test,gyrA quinolone resistance determining region (QRDR) DNA sequencing and DHPLC analysis concurrently. Results Two new characteristics of ofloxacin-resistant Mycobacterium tuberculosis were found: one was the high rate of double mutations in gyrA QRDR (56.3% of 87 ofloxacin-resistant isolates were found carrying double mutations),the other was that among these double-mutated isolates,20.4% (10/49) harbored the Ala74Ser mutation,which previously was thought to exist only in other bacteria,and had never been found in Mycobacterium tuberculosis. No close relationship was observed between gyrA mutation type and ofloxacin MIC. By introducing M.tb H37Rv and M.tb Erdman two reference strains,interference from codon 95 AGC:ACC polymorphism was successfully avoided. Compared to DNA sequencing,the sensitivity and specificity of DHPLC method were all 100%.Conclusions Fluoroquinolone-resistance of Mycobacterium tuberculosis in our country is quite severe. The characteristic is the high rate of gyrA QRDR double point mutations. DHPLC method set up in this work is simple,rapid,stable,sensitive and may be valuable in large samples of drug-resistance survillence in large area.
出处 《中华生物医学工程杂志》 CAS 2008年第1期-,共5页 Chinese Journal of Biomedical Engineering
基金 河南省医学科技攻关重点项目
  • 相关文献

参考文献11

  • 1Ginsburg AS,Grosset JH,Bishai WR. Fluoroquinolones,tuberculosis,and resistance[J].Lancet Infectious Diseases,2003.432-442.
  • 2Cooksey RC,Morlock GP,Holloway BP. Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms[J].Journal of Clinical Microbiology,2002,(5):1610-1616.doi:10.1128/JCM.40.5.1610-1616.2002.
  • 3Ruiru S,Otomo K,Yamada H. Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC,SURVEYOR nuclease[J].Microbes and Infection,2006,(1):128-135.doi:10.1016/j.micinf.2005.06.008.
  • 4Kocagoz T,Hackbarth CJ,Unsal I. Gyrase mutation in laboratory selected,fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra[J].Antimicrobial Agents and Chemotherapy,1996.1768-1774.
  • 5Cheng AF,Yew WW,Chan EW. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates[J].Antimicrobial Agents and Chemotherapy,2004,(2):596-601.doi:10.1128/AAC.48.2.596-601.2004.
  • 6Takiff H,Salazar L,Guerrero C. Cloning and nucleotide sequence of the Mycobacterium tuberculosis gyrA and gyrB genes,and detection of quinolone resistance mutations[J].Antimicrobial Agents and Chemotherapy,1994.773-780.
  • 7Xu C,Kreiswirth BN,Sreeratsan S. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis[J].Journal of Infectious Diseases,1996.1127-1130.
  • 8Ginsburg AS,Sun R,Calamita H. Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model[J].Antimicrobial Agents and Chemotherapy,2005,(9):3977-3979.doi:10.1128/AAC.49.9.3977-3979.2005.
  • 9Bozeman L,Burman W,Metchock B. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada[J].Clinical Infectious Diseases,2005,(3):386-391.doi:10.1086/427292.
  • 10Grimaldo ER,Tupasi TE,Rivera AB. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant Mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines[J].International Journal of Tuberculosis and Lung Disease,2001.546-550.

同被引文献18

  • 1石瑞如,杜长梅.特异性核酸内切酶检测结核分枝杆菌的乙胺丁醇耐药基因突变[J].中华结核和呼吸杂志,2006,29(10):702-704. 被引量:4
  • 2Zhao Y,Xu S,Wang L,et al.National survey of drug-resistant tuberculosis in China[J].N Engl J Med,2012,366:2161-2170.
  • 3Global Tuberculosis Programme.Global tuberculosis control:WHO report[M].Global Tuberculosis Programme,World Health Organization,2010.
  • 4Kalokhe AS,Shafiq M,Lee JC,et al.Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing[J].Am J Med Sci,2012,345:143-148.
  • 5Shi R,Itagaki N,Sugawara I.Overview of anti-tuberculosis(TB)drugs and their resistance mechanisms[J].Mini Rev Med Chem,2007,7:1177-1185.
  • 6Shi R,Otomo K,Yamada H,et al.Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutation in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC,SUVEYOR nuclease[J].Microb Infect,2006,8:128-135.
  • 7中华人民共和国医政司.全国临床检验操作规程:分枝杆菌的药物敏感性试验[M].3版.南京:东南大学出版社,2006:916-917.
  • 8Bemer P,Palicova F,Rusch-Gerdes S,et al.Multicenter evaluation of fully automated BACTEC Mycobacteric Growth Indication Tube 960 system for susceptibility testing of Mycobacterium tuberculosis[J].J Clin Microbiol,2002,40:150-154.
  • 9Kruuner A,Yates MD,Drobniewski FA.Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first-and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis[J].J Clin Microbial,2006,44:811-818.
  • 10Zhang L,Ye Y,Duo L,et al.Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China[J].Mol Biol Rep,2011,38:2185-2192.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部